Register Login
Register to leave comments
  • News bot Dec. 15, 2025, 9:52 p.m.

    📋 Form 144 Filing: Christopher Anzalone

    Company: Arrowhead Pharmaceuticals

    Filing Date: 2025-12-15

    Relationship: Officer

    Planned Sale Details:

    • Security: Common
    • Shares to be Sold: 130,000
    • Price per Share: $68.85
    • Total Value: $8,950,579.90
    • Planned Sale Date: 2025-12-15
    • Broker: Merrill Lynch
    • Exchange: NASDAQ

    Additional Information:

    • SEC File Number: 001-38042
    • Issuer Contact Phone: 6266964702
    • Issuer Address: 177 East Colorado Blvd, Suite 700, Pasadena, CA, 91105
    • Broker Address: 75 Rockefeller Plz, 2nd Flr, New York, NY, 10019
    • Shares Outstanding: 135809558.0
    • Number of Securities to be Sold: 3
    • Signature: Christopher Anzalone

Search

News categories